nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—ABCB1—kidney cancer	0.246	1	CbGaD
Indacaterol—UGT1A1—Pazopanib—kidney cancer	0.115	0.196	CbGbCtD
Indacaterol—UGT1A1—Erlotinib—kidney cancer	0.0821	0.14	CbGbCtD
Indacaterol—UGT1A1—Sorafenib—kidney cancer	0.0668	0.113	CbGbCtD
Indacaterol—ABCB1—Temsirolimus—kidney cancer	0.0434	0.0738	CbGbCtD
Indacaterol—CYP3A4—Everolimus—kidney cancer	0.0385	0.0655	CbGbCtD
Indacaterol—CYP3A4—Temsirolimus—kidney cancer	0.026	0.0442	CbGbCtD
Indacaterol—ABCB1—Pazopanib—kidney cancer	0.0228	0.0388	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—kidney cancer	0.0209	0.0355	CbGbCtD
Indacaterol—ABCB1—Gemcitabine—kidney cancer	0.0165	0.028	CbGbCtD
Indacaterol—ABCB1—Erlotinib—kidney cancer	0.0163	0.0277	CbGbCtD
Indacaterol—ABCB1—Paclitaxel—kidney cancer	0.0149	0.0253	CbGbCtD
Indacaterol—CYP3A4—Pazopanib—kidney cancer	0.0137	0.0232	CbGbCtD
Indacaterol—ABCB1—Sorafenib—kidney cancer	0.0132	0.0225	CbGbCtD
Indacaterol—ABCB1—Vinblastine—kidney cancer	0.0131	0.0222	CbGbCtD
Indacaterol—ABCB1—Vincristine—kidney cancer	0.0129	0.0219	CbGbCtD
Indacaterol—ABCB1—Sunitinib—kidney cancer	0.0107	0.0182	CbGbCtD
Indacaterol—CYP3A4—Erlotinib—kidney cancer	0.00976	0.0166	CbGbCtD
Indacaterol—CYP3A4—Paclitaxel—kidney cancer	0.00893	0.0152	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—kidney cancer	0.00803	0.0137	CbGbCtD
Indacaterol—CYP3A4—Sorafenib—kidney cancer	0.00793	0.0135	CbGbCtD
Indacaterol—CYP3A4—Vinblastine—kidney cancer	0.00783	0.0133	CbGbCtD
Indacaterol—CYP3A4—Vincristine—kidney cancer	0.0077	0.0131	CbGbCtD
Indacaterol—CYP3A4—Sunitinib—kidney cancer	0.00643	0.0109	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—kidney cancer	0.00481	0.00818	CbGbCtD
Indacaterol—UGT1A1—urine—kidney cancer	0.0029	0.421	CbGeAlD
Indacaterol—CYP3A4—urine—kidney cancer	0.000931	0.135	CbGeAlD
Indacaterol—UGT1A1—renal system—kidney cancer	0.000711	0.103	CbGeAlD
Indacaterol—UGT1A1—kidney—kidney cancer	0.000687	0.0995	CbGeAlD
Indacaterol—ADRB1—cardiac atrium—kidney cancer	0.000431	0.0624	CbGeAlD
Indacaterol—Hypersensitivity—Temsirolimus—kidney cancer	0.000371	0.00252	CcSEcCtD
Indacaterol—Atrial fibrillation—Capecitabine—kidney cancer	0.00037	0.00252	CcSEcCtD
Indacaterol—Muscle spasms—Sunitinib—kidney cancer	0.000368	0.00251	CcSEcCtD
Indacaterol—Anaemia—Sorafenib—kidney cancer	0.000368	0.00251	CcSEcCtD
Indacaterol—Nervous system disorder—Everolimus—kidney cancer	0.000367	0.0025	CcSEcCtD
Indacaterol—Connective tissue disorder—Vincristine—kidney cancer	0.000366	0.00249	CcSEcCtD
Indacaterol—Tachycardia—Everolimus—kidney cancer	0.000365	0.00249	CcSEcCtD
Indacaterol—Skin disorder—Everolimus—kidney cancer	0.000364	0.00248	CcSEcCtD
Indacaterol—Infection—Erlotinib—kidney cancer	0.000359	0.00244	CcSEcCtD
Indacaterol—Pruritus—Temsirolimus—kidney cancer	0.000356	0.00242	CcSEcCtD
Indacaterol—Nervous system disorder—Erlotinib—kidney cancer	0.000354	0.00241	CcSEcCtD
Indacaterol—Anaemia—Sunitinib—kidney cancer	0.000354	0.00241	CcSEcCtD
Indacaterol—Skin disorder—Erlotinib—kidney cancer	0.000351	0.00239	CcSEcCtD
Indacaterol—Oedema peripheral—Gemcitabine—kidney cancer	0.000348	0.00237	CcSEcCtD
Indacaterol—Cough—Sorafenib—kidney cancer	0.000347	0.00237	CcSEcCtD
Indacaterol—Connective tissue disorder—Gemcitabine—kidney cancer	0.000347	0.00236	CcSEcCtD
Indacaterol—Cardiac disorder—Vincristine—kidney cancer	0.000345	0.00235	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000343	0.00234	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000341	0.00232	CcSEcCtD
Indacaterol—Myalgia—Sorafenib—kidney cancer	0.000339	0.00231	CcSEcCtD
Indacaterol—Paraesthesia—Vinblastine—kidney cancer	0.000337	0.0023	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000337	0.00229	CcSEcCtD
Indacaterol—Paraesthesia—Everolimus—kidney cancer	0.000336	0.00229	CcSEcCtD
Indacaterol—Mediastinal disorder—Vincristine—kidney cancer	0.000335	0.00228	CcSEcCtD
Indacaterol—Pruritus—Pazopanib—kidney cancer	0.000335	0.00228	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—kidney cancer	0.000335	0.00228	CcSEcCtD
Indacaterol—Cough—Sunitinib—kidney cancer	0.000334	0.00228	CcSEcCtD
Indacaterol—Dyspnoea—Everolimus—kidney cancer	0.000334	0.00227	CcSEcCtD
Indacaterol—Hyperglycaemia—Paclitaxel—kidney cancer	0.000333	0.00227	CcSEcCtD
Indacaterol—Dizziness—Temsirolimus—kidney cancer	0.000333	0.00227	CcSEcCtD
Indacaterol—Dry mouth—Sorafenib—kidney cancer	0.000331	0.00226	CcSEcCtD
Indacaterol—Pneumonia—Paclitaxel—kidney cancer	0.000331	0.00226	CcSEcCtD
Indacaterol—Infestation—Paclitaxel—kidney cancer	0.000329	0.00224	CcSEcCtD
Indacaterol—Infestation NOS—Paclitaxel—kidney cancer	0.000329	0.00224	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000329	0.00224	CcSEcCtD
Indacaterol—Cardiac disorder—Gemcitabine—kidney cancer	0.000328	0.00223	CcSEcCtD
Indacaterol—Myalgia—Sunitinib—kidney cancer	0.000326	0.00222	CcSEcCtD
Indacaterol—Chest pain—Sunitinib—kidney cancer	0.000326	0.00222	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000324	0.00221	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Everolimus—kidney cancer	0.000323	0.0022	CcSEcCtD
Indacaterol—Infection—Sorafenib—kidney cancer	0.000323	0.0022	CcSEcCtD
Indacaterol—Dyspnoea—Erlotinib—kidney cancer	0.000322	0.00219	CcSEcCtD
Indacaterol—Hypokalaemia—Capecitabine—kidney cancer	0.000319	0.00217	CcSEcCtD
Indacaterol—Dry mouth—Sunitinib—kidney cancer	0.000319	0.00217	CcSEcCtD
Indacaterol—Immune system disorder—Gemcitabine—kidney cancer	0.000319	0.00217	CcSEcCtD
Indacaterol—Nervous system disorder—Sorafenib—kidney cancer	0.000319	0.00217	CcSEcCtD
Indacaterol—Mediastinal disorder—Gemcitabine—kidney cancer	0.000318	0.00217	CcSEcCtD
Indacaterol—Rash—Temsirolimus—kidney cancer	0.000317	0.00216	CcSEcCtD
Indacaterol—Dermatitis—Temsirolimus—kidney cancer	0.000317	0.00216	CcSEcCtD
Indacaterol—Skin disorder—Sorafenib—kidney cancer	0.000316	0.00215	CcSEcCtD
Indacaterol—Headache—Temsirolimus—kidney cancer	0.000315	0.00215	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—kidney cancer	0.000315	0.00215	CcSEcCtD
Indacaterol—Nasopharyngitis—Capecitabine—kidney cancer	0.000314	0.00214	CcSEcCtD
Indacaterol—Dizziness—Pazopanib—kidney cancer	0.000313	0.00214	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000312	0.00212	CcSEcCtD
Indacaterol—Infection—Sunitinib—kidney cancer	0.000311	0.00212	CcSEcCtD
Indacaterol—Sinusitis—Paclitaxel—kidney cancer	0.000309	0.0021	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—kidney cancer	0.000309	0.0021	CcSEcCtD
Indacaterol—Nervous system disorder—Sunitinib—kidney cancer	0.000307	0.00209	CcSEcCtD
Indacaterol—Skin disorder—Sunitinib—kidney cancer	0.000304	0.00207	CcSEcCtD
Indacaterol—Asthma—Capecitabine—kidney cancer	0.000303	0.00206	CcSEcCtD
Indacaterol—Anaemia—Vincristine—kidney cancer	0.000299	0.00204	CcSEcCtD
Indacaterol—Rash—Pazopanib—kidney cancer	0.000299	0.00204	CcSEcCtD
Indacaterol—Nausea—Temsirolimus—kidney cancer	0.000299	0.00204	CcSEcCtD
Indacaterol—Dermatitis—Pazopanib—kidney cancer	0.000299	0.00203	CcSEcCtD
Indacaterol—Bronchospasm—Capecitabine—kidney cancer	0.000298	0.00203	CcSEcCtD
Indacaterol—Headache—Pazopanib—kidney cancer	0.000297	0.00202	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000296	0.00202	CcSEcCtD
Indacaterol—Angina pectoris—Capecitabine—kidney cancer	0.000295	0.00201	CcSEcCtD
Indacaterol—Infection—Dactinomycin—kidney cancer	0.000294	0.002	CcSEcCtD
Indacaterol—Oedema peripheral—Paclitaxel—kidney cancer	0.000291	0.00198	CcSEcCtD
Indacaterol—Vertigo—Vincristine—kidney cancer	0.000291	0.00198	CcSEcCtD
Indacaterol—Connective tissue disorder—Paclitaxel—kidney cancer	0.00029	0.00198	CcSEcCtD
Indacaterol—Dyspnoea—Sorafenib—kidney cancer	0.00029	0.00197	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000285	0.00194	CcSEcCtD
Indacaterol—Anaemia—Gemcitabine—kidney cancer	0.000284	0.00193	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000282	0.00192	CcSEcCtD
Indacaterol—Nausea—Pazopanib—kidney cancer	0.000282	0.00192	CcSEcCtD
Indacaterol—Paraesthesia—Sunitinib—kidney cancer	0.000281	0.00191	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00028	0.00191	CcSEcCtD
Indacaterol—Dyspnoea—Sunitinib—kidney cancer	0.000279	0.0019	CcSEcCtD
Indacaterol—Hypersensitivity—Vinblastine—kidney cancer	0.000277	0.00189	CcSEcCtD
Indacaterol—Myalgia—Vincristine—kidney cancer	0.000276	0.00188	CcSEcCtD
Indacaterol—Hypersensitivity—Everolimus—kidney cancer	0.000276	0.00188	CcSEcCtD
Indacaterol—Cardiac disorder—Paclitaxel—kidney cancer	0.000274	0.00187	CcSEcCtD
Indacaterol—Hyperglycaemia—Capecitabine—kidney cancer	0.000273	0.00186	CcSEcCtD
Indacaterol—Pneumonia—Capecitabine—kidney cancer	0.000272	0.00185	CcSEcCtD
Indacaterol—Infestation—Capecitabine—kidney cancer	0.00027	0.00184	CcSEcCtD
Indacaterol—Infestation NOS—Capecitabine—kidney cancer	0.00027	0.00184	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00027	0.00184	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00027	0.00184	CcSEcCtD
Indacaterol—Cough—Gemcitabine—kidney cancer	0.000268	0.00183	CcSEcCtD
Indacaterol—Immune system disorder—Paclitaxel—kidney cancer	0.000267	0.00182	CcSEcCtD
Indacaterol—Mediastinal disorder—Paclitaxel—kidney cancer	0.000266	0.00181	CcSEcCtD
Indacaterol—Pruritus—Everolimus—kidney cancer	0.000265	0.0018	CcSEcCtD
Indacaterol—Infection—Vincristine—kidney cancer	0.000263	0.00179	CcSEcCtD
Indacaterol—Chest pain—Gemcitabine—kidney cancer	0.000262	0.00178	CcSEcCtD
Indacaterol—Myalgia—Gemcitabine—kidney cancer	0.000262	0.00178	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—kidney cancer	0.00026	0.00177	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00026	0.00177	CcSEcCtD
Indacaterol—Nervous system disorder—Vincristine—kidney cancer	0.000259	0.00177	CcSEcCtD
Indacaterol—Malnutrition—Paclitaxel—kidney cancer	0.000257	0.00175	CcSEcCtD
Indacaterol—Pruritus—Erlotinib—kidney cancer	0.000255	0.00174	CcSEcCtD
Indacaterol—Infection—Gemcitabine—kidney cancer	0.000249	0.0017	CcSEcCtD
Indacaterol—Dizziness—Vinblastine—kidney cancer	0.000248	0.00169	CcSEcCtD
Indacaterol—Dizziness—Everolimus—kidney cancer	0.000247	0.00169	CcSEcCtD
Indacaterol—Muscle spasms—Paclitaxel—kidney cancer	0.000247	0.00169	CcSEcCtD
Indacaterol—Nervous system disorder—Gemcitabine—kidney cancer	0.000246	0.00168	CcSEcCtD
Indacaterol—Skin disorder—Gemcitabine—kidney cancer	0.000244	0.00166	CcSEcCtD
Indacaterol—Tremor—Paclitaxel—kidney cancer	0.000241	0.00164	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000241	0.00164	CcSEcCtD
Indacaterol—Hypersensitivity—Sorafenib—kidney cancer	0.000239	0.00163	CcSEcCtD
Indacaterol—Oedema peripheral—Capecitabine—kidney cancer	0.000239	0.00163	CcSEcCtD
Indacaterol—Dizziness—Erlotinib—kidney cancer	0.000239	0.00163	CcSEcCtD
Indacaterol—Connective tissue disorder—Capecitabine—kidney cancer	0.000238	0.00162	CcSEcCtD
Indacaterol—Anaemia—Paclitaxel—kidney cancer	0.000238	0.00162	CcSEcCtD
Indacaterol—Paraesthesia—Vincristine—kidney cancer	0.000237	0.00162	CcSEcCtD
Indacaterol—Rash—Everolimus—kidney cancer	0.000236	0.00161	CcSEcCtD
Indacaterol—Dermatitis—Everolimus—kidney cancer	0.000236	0.00161	CcSEcCtD
Indacaterol—Headache—Vinblastine—kidney cancer	0.000235	0.0016	CcSEcCtD
Indacaterol—Headache—Everolimus—kidney cancer	0.000234	0.0016	CcSEcCtD
Indacaterol—Vertigo—Paclitaxel—kidney cancer	0.000231	0.00157	CcSEcCtD
Indacaterol—Hypersensitivity—Sunitinib—kidney cancer	0.00023	0.00157	CcSEcCtD
Indacaterol—Pruritus—Sorafenib—kidney cancer	0.00023	0.00157	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000229	0.00156	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Vincristine—kidney cancer	0.000228	0.00155	CcSEcCtD
Indacaterol—CYP3A4—renal system—kidney cancer	0.000228	0.033	CbGeAlD
Indacaterol—Rash—Erlotinib—kidney cancer	0.000228	0.00155	CcSEcCtD
Indacaterol—Dermatitis—Erlotinib—kidney cancer	0.000227	0.00155	CcSEcCtD
Indacaterol—Palpitations—Paclitaxel—kidney cancer	0.000227	0.00155	CcSEcCtD
Indacaterol—Headache—Erlotinib—kidney cancer	0.000226	0.00154	CcSEcCtD
Indacaterol—Paraesthesia—Gemcitabine—kidney cancer	0.000225	0.00153	CcSEcCtD
Indacaterol—Cardiac disorder—Capecitabine—kidney cancer	0.000225	0.00153	CcSEcCtD
Indacaterol—Cough—Paclitaxel—kidney cancer	0.000225	0.00153	CcSEcCtD
Indacaterol—Dyspnoea—Gemcitabine—kidney cancer	0.000224	0.00152	CcSEcCtD
Indacaterol—Nausea—Vinblastine—kidney cancer	0.000223	0.00152	CcSEcCtD
Indacaterol—Nausea—Everolimus—kidney cancer	0.000222	0.00151	CcSEcCtD
Indacaterol—Pruritus—Sunitinib—kidney cancer	0.000221	0.00151	CcSEcCtD
Indacaterol—CYP3A4—kidney—kidney cancer	0.00022	0.0319	CbGeAlD
Indacaterol—Immune system disorder—Capecitabine—kidney cancer	0.000219	0.00149	CcSEcCtD
Indacaterol—Chest pain—Paclitaxel—kidney cancer	0.000219	0.00149	CcSEcCtD
Indacaterol—Myalgia—Paclitaxel—kidney cancer	0.000219	0.00149	CcSEcCtD
Indacaterol—Mediastinal disorder—Capecitabine—kidney cancer	0.000219	0.00149	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—kidney cancer	0.000218	0.00149	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000218	0.00148	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000217	0.00148	CcSEcCtD
Indacaterol—Dizziness—Sorafenib—kidney cancer	0.000215	0.00146	CcSEcCtD
Indacaterol—Nausea—Erlotinib—kidney cancer	0.000214	0.00146	CcSEcCtD
Indacaterol—Dry mouth—Paclitaxel—kidney cancer	0.000214	0.00146	CcSEcCtD
Indacaterol—Malnutrition—Capecitabine—kidney cancer	0.000211	0.00144	CcSEcCtD
Indacaterol—Infection—Paclitaxel—kidney cancer	0.000209	0.00142	CcSEcCtD
Indacaterol—Dizziness—Sunitinib—kidney cancer	0.000207	0.00141	CcSEcCtD
Indacaterol—Nervous system disorder—Paclitaxel—kidney cancer	0.000206	0.0014	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—kidney cancer	0.000206	0.0014	CcSEcCtD
Indacaterol—Tachycardia—Paclitaxel—kidney cancer	0.000205	0.0014	CcSEcCtD
Indacaterol—Rash—Sorafenib—kidney cancer	0.000205	0.0014	CcSEcCtD
Indacaterol—Dermatitis—Sorafenib—kidney cancer	0.000205	0.00139	CcSEcCtD
Indacaterol—Skin disorder—Paclitaxel—kidney cancer	0.000204	0.00139	CcSEcCtD
Indacaterol—Headache—Sorafenib—kidney cancer	0.000204	0.00139	CcSEcCtD
Indacaterol—Muscle spasms—Capecitabine—kidney cancer	0.000203	0.00138	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—kidney cancer	0.000202	0.00138	CcSEcCtD
Indacaterol—Tremor—Capecitabine—kidney cancer	0.000198	0.00135	CcSEcCtD
Indacaterol—Rash—Sunitinib—kidney cancer	0.000197	0.00134	CcSEcCtD
Indacaterol—Dermatitis—Sunitinib—kidney cancer	0.000197	0.00134	CcSEcCtD
Indacaterol—Headache—Sunitinib—kidney cancer	0.000196	0.00133	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—kidney cancer	0.000195	0.00133	CcSEcCtD
Indacaterol—Anaemia—Capecitabine—kidney cancer	0.000195	0.00133	CcSEcCtD
Indacaterol—Hypersensitivity—Vincristine—kidney cancer	0.000195	0.00133	CcSEcCtD
Indacaterol—Nausea—Sorafenib—kidney cancer	0.000193	0.00131	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000191	0.0013	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—kidney cancer	0.00019	0.0013	CcSEcCtD
Indacaterol—Vertigo—Capecitabine—kidney cancer	0.00019	0.00129	CcSEcCtD
Indacaterol—Paraesthesia—Paclitaxel—kidney cancer	0.000189	0.00128	CcSEcCtD
Indacaterol—Dyspnoea—Paclitaxel—kidney cancer	0.000187	0.00128	CcSEcCtD
Indacaterol—Palpitations—Capecitabine—kidney cancer	0.000187	0.00127	CcSEcCtD
Indacaterol—Rash—Dactinomycin—kidney cancer	0.000187	0.00127	CcSEcCtD
Indacaterol—Nausea—Sunitinib—kidney cancer	0.000186	0.00126	CcSEcCtD
Indacaterol—Cough—Capecitabine—kidney cancer	0.000184	0.00126	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000182	0.00124	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000181	0.00123	CcSEcCtD
Indacaterol—Chest pain—Capecitabine—kidney cancer	0.00018	0.00122	CcSEcCtD
Indacaterol—Myalgia—Capecitabine—kidney cancer	0.00018	0.00122	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000179	0.00122	CcSEcCtD
Indacaterol—Pruritus—Gemcitabine—kidney cancer	0.000177	0.00121	CcSEcCtD
Indacaterol—ABCB1—nephron tubule—kidney cancer	0.000177	0.0257	CbGeAlD
Indacaterol—Hyperglycaemia—Doxorubicin—kidney cancer	0.000176	0.0012	CcSEcCtD
Indacaterol—Dry mouth—Capecitabine—kidney cancer	0.000176	0.0012	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—kidney cancer	0.000176	0.0012	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—kidney cancer	0.000175	0.00119	CcSEcCtD
Indacaterol—Dizziness—Vincristine—kidney cancer	0.000175	0.00119	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—kidney cancer	0.000174	0.00119	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—kidney cancer	0.000174	0.00119	CcSEcCtD
Indacaterol—Infection—Capecitabine—kidney cancer	0.000171	0.00117	CcSEcCtD
Indacaterol—Nervous system disorder—Capecitabine—kidney cancer	0.000169	0.00115	CcSEcCtD
Indacaterol—Tachycardia—Capecitabine—kidney cancer	0.000168	0.00115	CcSEcCtD
Indacaterol—Skin disorder—Capecitabine—kidney cancer	0.000167	0.00114	CcSEcCtD
Indacaterol—Rash—Vincristine—kidney cancer	0.000167	0.00114	CcSEcCtD
Indacaterol—Dermatitis—Vincristine—kidney cancer	0.000167	0.00113	CcSEcCtD
Indacaterol—Headache—Vincristine—kidney cancer	0.000166	0.00113	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—kidney cancer	0.000163	0.00111	CcSEcCtD
Indacaterol—ABCB1—renal system—kidney cancer	0.000161	0.0234	CbGeAlD
Indacaterol—Rash—Gemcitabine—kidney cancer	0.000158	0.00108	CcSEcCtD
Indacaterol—Dermatitis—Gemcitabine—kidney cancer	0.000158	0.00108	CcSEcCtD
Indacaterol—Headache—Gemcitabine—kidney cancer	0.000157	0.00107	CcSEcCtD
Indacaterol—Nausea—Vincristine—kidney cancer	0.000157	0.00107	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000157	0.00107	CcSEcCtD
Indacaterol—ABCB1—kidney—kidney cancer	0.000156	0.0226	CbGeAlD
Indacaterol—Paraesthesia—Capecitabine—kidney cancer	0.000155	0.00105	CcSEcCtD
Indacaterol—Hypersensitivity—Paclitaxel—kidney cancer	0.000155	0.00105	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—kidney cancer	0.000154	0.00105	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—kidney cancer	0.000154	0.00105	CcSEcCtD
Indacaterol—Dyspnoea—Capecitabine—kidney cancer	0.000154	0.00105	CcSEcCtD
Indacaterol—ABCB1—cortex of kidney—kidney cancer	0.000152	0.022	CbGeAlD
Indacaterol—Nausea—Gemcitabine—kidney cancer	0.000149	0.00101	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000149	0.00101	CcSEcCtD
Indacaterol—Pruritus—Paclitaxel—kidney cancer	0.000149	0.00101	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—kidney cancer	0.000145	0.000988	CcSEcCtD
Indacaterol—ABCB1—gonad—kidney cancer	0.000145	0.0209	CbGeAlD
Indacaterol—Immune system disorder—Doxorubicin—kidney cancer	0.000141	0.000962	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—kidney cancer	0.000141	0.00096	CcSEcCtD
Indacaterol—Dizziness—Paclitaxel—kidney cancer	0.000139	0.000946	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—kidney cancer	0.000136	0.000927	CcSEcCtD
Indacaterol—Rash—Paclitaxel—kidney cancer	0.000132	0.000902	CcSEcCtD
Indacaterol—Dermatitis—Paclitaxel—kidney cancer	0.000132	0.000901	CcSEcCtD
Indacaterol—Headache—Paclitaxel—kidney cancer	0.000132	0.000896	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—kidney cancer	0.000131	0.000891	CcSEcCtD
Indacaterol—Hypersensitivity—Capecitabine—kidney cancer	0.000127	0.000865	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—kidney cancer	0.000126	0.000857	CcSEcCtD
Indacaterol—Nausea—Paclitaxel—kidney cancer	0.000125	0.00085	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—kidney cancer	0.000122	0.000833	CcSEcCtD
Indacaterol—Pruritus—Capecitabine—kidney cancer	0.000122	0.000831	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—kidney cancer	0.00012	0.000819	CcSEcCtD
Indacaterol—Cough—Doxorubicin—kidney cancer	0.000119	0.000809	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—kidney cancer	0.000116	0.000789	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—kidney cancer	0.000116	0.000789	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000115	0.000784	CcSEcCtD
Indacaterol—Dizziness—Capecitabine—kidney cancer	0.000114	0.000776	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—kidney cancer	0.000113	0.000772	CcSEcCtD
Indacaterol—Infection—Doxorubicin—kidney cancer	0.00011	0.000752	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—kidney cancer	0.000109	0.000742	CcSEcCtD
Indacaterol—Rash—Capecitabine—kidney cancer	0.000109	0.00074	CcSEcCtD
Indacaterol—Dermatitis—Capecitabine—kidney cancer	0.000109	0.000739	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—kidney cancer	0.000108	0.000739	CcSEcCtD
Indacaterol—Headache—Capecitabine—kidney cancer	0.000108	0.000735	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—kidney cancer	0.000108	0.000735	CcSEcCtD
Indacaterol—Nausea—Capecitabine—kidney cancer	0.000102	0.000697	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000101	0.000689	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—kidney cancer	9.98e-05	0.000679	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—kidney cancer	9.9e-05	0.000675	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—kidney cancer	9.59e-05	0.000653	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—kidney cancer	8.18e-05	0.000558	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—kidney cancer	7.86e-05	0.000535	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—kidney cancer	7.35e-05	0.0005	CcSEcCtD
Indacaterol—Rash—Doxorubicin—kidney cancer	7e-05	0.000477	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—kidney cancer	7e-05	0.000477	CcSEcCtD
Indacaterol—Headache—Doxorubicin—kidney cancer	6.96e-05	0.000474	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—kidney cancer	6.6e-05	0.000449	CcSEcCtD
Indacaterol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.85e-05	0.00159	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ALDH1A1—kidney cancer	1.82e-05	0.00156	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	1.79e-05	0.00153	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—IL2—kidney cancer	1.78e-05	0.00153	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AMER1—kidney cancer	1.78e-05	0.00152	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	1.77e-05	0.00152	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTT1—kidney cancer	1.77e-05	0.00152	CbGpPWpGaD
Indacaterol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	1.75e-05	0.0015	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PGK1—kidney cancer	1.75e-05	0.0015	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC5A3—kidney cancer	1.75e-05	0.0015	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AMER1—kidney cancer	1.74e-05	0.00149	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—AKAP13—kidney cancer	1.73e-05	0.00148	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—LDHB—kidney cancer	1.71e-05	0.00147	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	1.71e-05	0.00147	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	1.71e-05	0.00147	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	1.71e-05	0.00147	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—AKAP13—kidney cancer	1.69e-05	0.00145	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—PTGS1—kidney cancer	1.66e-05	0.00142	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ITPR2—kidney cancer	1.62e-05	0.00139	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—ITPR2—kidney cancer	1.58e-05	0.00136	CbGpPWpGaD
Indacaterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	1.54e-05	0.00132	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ACY1—kidney cancer	1.53e-05	0.00131	CbGpPWpGaD
Indacaterol—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.51e-05	0.0013	CbGpPWpGaD
Indacaterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	1.51e-05	0.00129	CbGpPWpGaD
Indacaterol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.5e-05	0.00129	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CER1—kidney cancer	1.49e-05	0.00128	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GPC3—kidney cancer	1.49e-05	0.00128	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CA9—kidney cancer	1.49e-05	0.00127	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ITPR2—kidney cancer	1.47e-05	0.00126	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CER1—kidney cancer	1.46e-05	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GPC3—kidney cancer	1.46e-05	0.00125	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—ITPR2—kidney cancer	1.44e-05	0.00123	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—ANXA1—kidney cancer	1.35e-05	0.00116	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—ANXA1—kidney cancer	1.32e-05	0.00114	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PDHB—kidney cancer	1.3e-05	0.00111	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—SFRP2—kidney cancer	1.26e-05	0.00108	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CRABP1—kidney cancer	1.26e-05	0.00108	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	1.25e-05	0.00107	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—SFRP2—kidney cancer	1.24e-05	0.00106	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—ANXA1—kidney cancer	1.23e-05	0.00105	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.23e-05	0.00105	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CCBL1—kidney cancer	1.22e-05	0.00105	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.21e-05	0.00104	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—ANXA1—kidney cancer	1.2e-05	0.00103	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ITPR2—kidney cancer	1.17e-05	0.00101	CbGpPWpGaD
Indacaterol—ADRB1—GPCR ligand binding—POMC—kidney cancer	1.17e-05	0.00101	CbGpPWpGaD
Indacaterol—ADRB2—GPCR ligand binding—POMC—kidney cancer	1.15e-05	0.000984	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.13e-05	0.000967	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.11e-05	0.000954	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTT1—kidney cancer	1.07e-05	0.000918	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ACHE—kidney cancer	1.07e-05	0.000918	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.07e-05	0.000916	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GLIPR1—kidney cancer	1.06e-05	0.000907	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PPAT—kidney cancer	1.06e-05	0.000907	CbGpPWpGaD
Indacaterol—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.05e-05	0.000904	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—AKAP13—kidney cancer	1.02e-05	0.000874	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CASP2—kidney cancer	1.02e-05	0.000874	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SCARB1—kidney cancer	1.01e-05	0.000869	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS1—kidney cancer	1e-05	0.000861	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—AKAP13—kidney cancer	9.97e-06	0.000855	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CASP2—kidney cancer	9.97e-06	0.000855	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PSMD7—kidney cancer	9.84e-06	0.000844	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—APRT—kidney cancer	9.84e-06	0.000843	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—FH—kidney cancer	9.84e-06	0.000843	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	9.81e-06	0.000841	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	9.71e-06	0.000832	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	9.49e-06	0.000814	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ACY1—kidney cancer	9.4e-06	0.000806	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—BCHE—kidney cancer	9.33e-06	0.0008	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—GRB7—kidney cancer	9.32e-06	0.000799	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GPC3—kidney cancer	9.25e-06	0.000793	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC5A5—kidney cancer	9.22e-06	0.00079	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—GRB7—kidney cancer	9.12e-06	0.000782	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.03e-06	0.000774	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CA2—kidney cancer	9e-06	0.000771	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	8.99e-06	0.000771	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—SLC2A1—kidney cancer	8.9e-06	0.000763	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALAD—kidney cancer	8.77e-06	0.000752	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.72e-06	0.000748	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ITPR2—kidney cancer	8.67e-06	0.000743	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.57e-06	0.000735	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ST3GAL2—kidney cancer	8.56e-06	0.000734	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.56e-06	0.000733	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	8.49e-06	0.000728	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ITPR2—kidney cancer	8.48e-06	0.000727	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ALDH1A1—kidney cancer	8.36e-06	0.000717	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	8.28e-06	0.000709	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC5A3—kidney cancer	8.02e-06	0.000687	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PGK1—kidney cancer	8.02e-06	0.000687	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PDHB—kidney cancer	8e-06	0.000685	CbGpPWpGaD
Indacaterol—CYP3A4—Biological oxidations—POMC—kidney cancer	7.97e-06	0.000683	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—LDHB—kidney cancer	7.86e-06	0.000674	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CTNNA1—kidney cancer	7.86e-06	0.000674	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—EIF4EBP1—kidney cancer	7.81e-06	0.00067	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HSPB1—kidney cancer	7.81e-06	0.00067	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CTNNA1—kidney cancer	7.69e-06	0.000659	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—EIF4EBP1—kidney cancer	7.64e-06	0.000655	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HSPB1—kidney cancer	7.64e-06	0.000655	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CCBL1—kidney cancer	7.52e-06	0.000644	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.48e-06	0.000641	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTP1—kidney cancer	7.43e-06	0.000637	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PSMD7—kidney cancer	7.26e-06	0.000623	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC1—kidney cancer	7.26e-06	0.000623	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ANXA1—kidney cancer	7.26e-06	0.000623	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ANXA1—kidney cancer	7.11e-06	0.000609	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PSMD7—kidney cancer	7.11e-06	0.000609	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC1—kidney cancer	7.11e-06	0.000609	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	7.07e-06	0.000606	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—FLT1—kidney cancer	7.04e-06	0.000603	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—ABCB1—kidney cancer	7.03e-06	0.000603	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—FLT1—kidney cancer	6.88e-06	0.00059	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	6.88e-06	0.00059	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—GSTM1—kidney cancer	6.82e-06	0.000585	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CA9—kidney cancer	6.82e-06	0.000584	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.73e-06	0.000577	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—POMC—kidney cancer	6.63e-06	0.000569	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PAK1—kidney cancer	6.52e-06	0.000559	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUNB—kidney cancer	6.52e-06	0.000559	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.52e-06	0.000559	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PPAT—kidney cancer	6.52e-06	0.000559	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—POMC—kidney cancer	6.49e-06	0.000556	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—CYP1A1—kidney cancer	6.47e-06	0.000555	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUNB—kidney cancer	6.38e-06	0.000547	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PAK1—kidney cancer	6.38e-06	0.000547	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	6.36e-06	0.000545	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—APRT—kidney cancer	6.06e-06	0.000519	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—FH—kidney cancer	6.06e-06	0.000519	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—POMC—kidney cancer	6.02e-06	0.000516	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—POMC—kidney cancer	5.89e-06	0.000505	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.84e-06	0.000501	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CRABP1—kidney cancer	5.8e-06	0.000497	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GPC3—kidney cancer	5.7e-06	0.000488	CbGpPWpGaD
Indacaterol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.65e-06	0.000484	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA2—kidney cancer	5.54e-06	0.000475	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALAD—kidney cancer	5.4e-06	0.000463	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ITPR2—kidney cancer	5.39e-06	0.000462	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF2—kidney cancer	5.33e-06	0.000457	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN2B—kidney cancer	5.31e-06	0.000455	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.27e-06	0.000452	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF2—kidney cancer	5.22e-06	0.000447	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN2B—kidney cancer	5.19e-06	0.000445	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IGF1R—kidney cancer	5.16e-06	0.000442	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.15e-06	0.000442	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IGF1R—kidney cancer	5.04e-06	0.000432	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—RAF1—kidney cancer	4.97e-06	0.000426	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PGK1—kidney cancer	4.94e-06	0.000423	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.94e-06	0.000423	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—ACHE—kidney cancer	4.91e-06	0.000421	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTT1—kidney cancer	4.91e-06	0.000421	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—IL2—kidney cancer	4.9e-06	0.00042	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—RAF1—kidney cancer	4.86e-06	0.000417	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—LDHB—kidney cancer	4.84e-06	0.000415	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—POMC—kidney cancer	4.82e-06	0.000413	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—IL2—kidney cancer	4.8e-06	0.000411	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SCARB1—kidney cancer	4.65e-06	0.000399	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS1—kidney cancer	4.61e-06	0.000395	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PSMD7—kidney cancer	4.52e-06	0.000387	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—IL2—kidney cancer	4.45e-06	0.000382	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—IL2—kidney cancer	4.36e-06	0.000373	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—BCHE—kidney cancer	4.28e-06	0.000367	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—HIF1A—kidney cancer	4.24e-06	0.000364	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TSC2—kidney cancer	4.23e-06	0.000363	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC5A5—kidney cancer	4.23e-06	0.000363	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CA9—kidney cancer	4.2e-06	0.00036	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—HIF1A—kidney cancer	4.15e-06	0.000356	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TSC2—kidney cancer	4.14e-06	0.000355	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—SLC2A1—kidney cancer	4.08e-06	0.00035	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KDR—kidney cancer	4.06e-06	0.000348	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KDR—kidney cancer	3.97e-06	0.00034	CbGpPWpGaD
Indacaterol—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.9e-06	0.000334	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTGS2—kidney cancer	3.85e-06	0.00033	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—APC—kidney cancer	3.74e-06	0.000321	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KIT—kidney cancer	3.74e-06	0.000321	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—APC—kidney cancer	3.66e-06	0.000314	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KIT—kidney cancer	3.66e-06	0.000314	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK3—kidney cancer	3.58e-06	0.000307	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CRABP1—kidney cancer	3.57e-06	0.000306	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—POMC—kidney cancer	3.56e-06	0.000305	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—BRAF—kidney cancer	3.51e-06	0.000301	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK3—kidney cancer	3.5e-06	0.0003	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—POMC—kidney cancer	3.48e-06	0.000298	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—BRAF—kidney cancer	3.44e-06	0.000295	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—MAPK1—kidney cancer	3.41e-06	0.000292	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTP1—kidney cancer	3.41e-06	0.000292	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PTEN—kidney cancer	3.36e-06	0.000288	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—MAPK1—kidney cancer	3.33e-06	0.000286	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ITPR2—kidney cancer	3.32e-06	0.000285	CbGpPWpGaD
Indacaterol—ADRB1—GPCR downstream signaling—PIK3CA—kidney cancer	3.26e-06	0.000279	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—KRAS—kidney cancer	3.22e-06	0.000276	CbGpPWpGaD
Indacaterol—ADRB2—GPCR downstream signaling—PIK3CA—kidney cancer	3.18e-06	0.000273	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—KRAS—kidney cancer	3.15e-06	0.00027	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—GSTM1—kidney cancer	3.13e-06	0.000268	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTT1—kidney cancer	3.03e-06	0.00026	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ACHE—kidney cancer	3.03e-06	0.00026	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—CYP1A1—kidney cancer	2.97e-06	0.000254	CbGpPWpGaD
Indacaterol—ADRB1—Signaling by GPCR—PIK3CA—kidney cancer	2.96e-06	0.000253	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RAF1—kidney cancer	2.93e-06	0.000252	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—RELA—kidney cancer	2.92e-06	0.00025	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—ERBB2—kidney cancer	2.9e-06	0.000249	CbGpPWpGaD
Indacaterol—ADRB2—Signaling by GPCR—PIK3CA—kidney cancer	2.89e-06	0.000248	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RAF1—kidney cancer	2.87e-06	0.000246	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SCARB1—kidney cancer	2.87e-06	0.000246	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MTOR—kidney cancer	2.86e-06	0.000246	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—RELA—kidney cancer	2.86e-06	0.000245	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—ERBB2—kidney cancer	2.84e-06	0.000243	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS1—kidney cancer	2.84e-06	0.000243	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MTOR—kidney cancer	2.8e-06	0.00024	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PSMD7—kidney cancer	2.78e-06	0.000239	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	2.69e-06	0.00023	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—BCHE—kidney cancer	2.64e-06	0.000226	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—IL2—kidney cancer	2.63e-06	0.000226	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CDKN1B—kidney cancer	2.63e-06	0.000225	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.61e-06	0.000223	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—IL2—kidney cancer	2.57e-06	0.000221	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CCND1—kidney cancer	2.56e-06	0.00022	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—JUN—kidney cancer	2.56e-06	0.000219	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	2.54e-06	0.000218	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.52e-06	0.000216	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CCND1—kidney cancer	2.51e-06	0.000215	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—JUN—kidney cancer	2.5e-06	0.000215	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—CTNNB1—kidney cancer	2.48e-06	0.000213	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PTEN—kidney cancer	2.48e-06	0.000212	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PTEN—kidney cancer	2.42e-06	0.000208	CbGpPWpGaD
Indacaterol—UGT1A1—Metabolism—PIK3CA—kidney cancer	2.37e-06	0.000203	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—VEGFA—kidney cancer	2.24e-06	0.000192	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—POMC—kidney cancer	2.21e-06	0.00019	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—VEGFA—kidney cancer	2.19e-06	0.000188	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK3—kidney cancer	2.12e-06	0.000181	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTP1—kidney cancer	2.1e-06	0.00018	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK3—kidney cancer	2.07e-06	0.000177	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MYC—kidney cancer	2.06e-06	0.000176	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—MAPK1—kidney cancer	2.01e-06	0.000173	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MYC—kidney cancer	2.01e-06	0.000173	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—ABCB1—kidney cancer	1.99e-06	0.00017	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—MAPK1—kidney cancer	1.97e-06	0.000169	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—GSTM1—kidney cancer	1.93e-06	0.000165	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—KRAS—kidney cancer	1.9e-06	0.000163	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—KRAS—kidney cancer	1.86e-06	0.000159	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.83e-06	0.000157	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTGS2—kidney cancer	1.76e-06	0.000151	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	1.75e-06	0.00015	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—PIK3CA—kidney cancer	1.71e-06	0.000146	CbGpPWpGaD
Indacaterol—ADRB1—Signaling Pathways—TP53—kidney cancer	1.69e-06	0.000145	CbGpPWpGaD
Indacaterol—ADRB2—Signaling Pathways—TP53—kidney cancer	1.65e-06	0.000142	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PTEN—kidney cancer	1.54e-06	0.000132	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—POMC—kidney cancer	1.36e-06	0.000117	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTGS2—kidney cancer	1.09e-06	9.32e-05	CbGpPWpGaD
Indacaterol—ABCB1—Metabolism—PIK3CA—kidney cancer	1.09e-06	9.31e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PTEN—kidney cancer	9.48e-07	8.13e-05	CbGpPWpGaD
Indacaterol—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.69e-07	5.73e-05	CbGpPWpGaD
